Adjuvant Osimertinib in EGFR-Mutated Non-Small-Cell Lung Cancer
- PMID: 33113300
- DOI: 10.1056/NEJMe2029532
Adjuvant Osimertinib in EGFR-Mutated Non-Small-Cell Lung Cancer
Comment on
-
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.N Engl J Med. 2020 Oct 29;383(18):1711-1723. doi: 10.1056/NEJMoa2027071. Epub 2020 Sep 19. N Engl J Med. 2020. PMID: 32955177 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous